Anticoagulant Effects of Dabigatran on Coagulation Laboratory Parameters in Pediatric Patients: Combined Data from Five Pediatric Clinical Trials

Background  Dabigatran etexilate, a direct oral thrombin inhibitor, is approved to treat venous thromboembolism (VTE) in both adults and children. Objectives  This population analysis characterized relationships between dabigatran total plasma concentrations and coagulation laboratory parameters (ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitchell, Lesley G., Röshammar, Daniel, Huang, Fenglei, Albisetti, Manuela, Brandão, Leonardo R., Bomgaars, Lisa, Chalmers, Elizabeth, Halton, Jacqueline, Luciani, Matteo, Joseph, David, Tartakovsky, Igor, Gropper, Savion, Brueckmann, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420551/
https://www.ncbi.nlm.nih.gov/pubmed/35909257
http://dx.doi.org/10.1055/s-0042-1744542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420551/
https://www.ncbi.nlm.nih.gov/pubmed/35909257
http://dx.doi.org/10.1055/s-0042-1744542

Ejemplares similares